Variation in drug responses & Drug-Drug Interactions

Similar documents
Tamer Barakat. Abdul Aziz ALShamali. Abdul Aziz ALShamali

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Introduction to Pharmacology

2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING

2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Chapter Goal. Learning Objectives 9/11/2012. Chapter 5. Emergency Pharmacology

Posology. Posology and Dosage Regimen: Factors Affecting Drug Dosage: 08/09/ ) Age: 1. Young s Rule, based on age:

3. Describe how variants in the CYP2C19 gene impact Plavix metabolism. 4. Compare molecular genetic technologies for pharmacogenomics testing

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Pharmacology in the Elderly

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Introducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building

MTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Drug + Receptor Drug receptor complex Biologic effect

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital

Aging Changes That Impact Medication Management

Cytochrome P450 Drug Interaction Table Flockhart Table

Composition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

2/25/2016. Pharmacodynamics of Aging Narrowing of the Therapeutic Index in the Face of Therapeutic Opportunity. Educational Objectives

Pharmacodynamics of Aging Narrowing of the Therapeutic Index in the Face of Therapeutic Opportunity

A. Definition. B. Epidemiology. C. Classification. i. Pharmacokinetic DIs. ii. Pharmacodynamic DIs. D. Recognition. E. Prevention

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pharmacokinetics for Physicians. Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne

SUMMARY OF PRODUCT CHARATERISTICS HYPERIUM. I.N.N. : Rilmenidine

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

Prescribing Drugs to the Elderly

Drug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)

Renal Excretion of Drugs

SIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product.

COMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan

How to Teach About Drugs and Aging

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Pharmacogenetics and Pharmacokinetics

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

MR04A3 An isoindoline derivative, New Sedative/Anesthetic Agent

When choosing an antiepileptic ... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs. Based on a presentation by Barry E.

Pharmacokinetics in the critically ill. Intensive Care Training Program Radboud University Medical Centre Nijmegen

BASIC PHARMACOKINETICS

Can PK and Modelling Help?

Chapter 5. The Actions of Drugs. Origins of Drugs. Names of Drugs. Most drugs come from plants or are chemically derived from plants

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

Renal Impairment From Dettli to Guideline: What can we learn?

Physiotens 0.2 mg Abbott

Chapter : Sources and Bodily Effect of Drugs

Section 5.2: Pharmacokinetic properties

Each 5ml of Sinarest LP New Syrup contains: Phenylephrine

INSPRA 25 & 50 mg TABLETS

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

CYP2D6: mirtazapine 2001/2002/2003

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

Mental Health DNA Insight WHITE PAPER

AROMASIN 25mg (Tablets)

MEDICATION PORTFOLIO Medication Generic Brand Pharmkinetics. Other nursing implications. Dose / route. Pharmdynamics. Side effects

Geriatric Pharmacology

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

Prescribing and Pharmacokinetic Considerations in the Elderly

PARACOD Tablets (Paracetamol + Codeine phosphate)

PRESCRIBING IN LIVER AND RENAL DISEASE

Cetirizine Proposed Core Safety Profile

Pharmacokinetic Phase

Principle of Pharmacology. Higher Diploma in Nursing Year 1 Pathophysiology and Pharmacology

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Drug Interactions Year 2 Clinical Pharmacology

Guidelines for Urine Drug Monitoring for the Pain Patient in a Clinical Practice

Each tablet contains:

Risperidone Case 1: Drug-Drug Interactions

Basic Principles in Pharmacology

Principles of Pharmacology. Pharmacokinetics & Pharmacodynamics. Mr. D.Raju, M.pharm, Lecturer PHL-358-PHARMACOLOGY AND THERAPEUTICS-I

Pharmacodynamics & Pharmacokinetics 1

Lippincott Questions Pharmacology

CYP2D6 and the oestrogen receptor

INTRODUCTION TO PHARMACOKINETICS

Introduction to Pharmacokinetics

PHARMACOKINETICS SMALL GROUP I:

DRUGS THAT ACT IN THE CNS

DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 37 TOP: NURSING PROCESS: General MSC: NCLEX: Health Promotion and Maintenance

CAYUGA COMMUNITY COLLEGE Division of Computer Science, Mechanical Technology, Electrical Technology, GIS, Math, Nursing, Science

SUMMARY OF PRODUCT CHARACTERISTICS

Adverse drug reactions. Dr. Mark Haworth MBChB DA MRCA

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Drug Use in Dialysis

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Farmadol. Paracetamol 10 mg/ml INFUSION SOLUTION

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Transcription:

Variation in drug responses & Drug-Drug Interactions 1

Properties of an Ideal Drug Effective Safety Selective Reversible Action Predictable Freedom from drug interactions Low cost Chemically stable

Sources of Variability in Therapeutic Responses Similar drugs usually produce similar qualities of responses in patients, but might produce different intensities and duration of effects. Dose, Dosage schedule, and Route of administration. Diurnal variation Chronopharmacology. Age and sex of the patient. Drug reactions. Drug interactions: other drugs, diet, and environment. Placebo effect. Intercurrent illnesses. Tolerance. Genetic or racial factors, Pharmacogenetics.

Causes of Variability in Drug Response Those related to the biological system 1. Body weight and size 2. Age and Sex 3. Genetics - pharmacogenetics 4. Condition of health 5. Placebo effect

Causes of Variability in Drug Response Those related to the conditions of administration 1. Dose, formulation, route of administration. 2. Resulting from repeated administration of drug: drug resistance; drug tolerance-tachyphylaxis; drug allergy 3. Drug interactions: chemical or physical; GI absorption; protein binding/distribution; metabolism (stimulation/inhibition); excretion (ph/transport processes); receptor (potentiation/antagonism); changes in ph or electrolytes.

Pharmacogenomics: The relation between the individual s genetic makeup to his/her response to specific drugs (entire genome). Pharmacogenetics: Interindividual variation in drug response that is due to genetic influences (specific gene). 6

Phenotypes of CYP450 1. Poor metabolizer (PM) - has low metabolic capacity - has two mutant alleles 2. Intermediate metabolizer (IM) - has metabolic capacity between PM and EM -has one reduced activity allele and one null 3. Extensive metabolizer (EM) - has regular metabolic capacity - has at least one and no more than two normal functioning alleles 4. Ultrarapid metabolizer (UM) - has higher metabolic capacity than EM - has multiple copies of functional alleles

Drug-drug interaction When two drugs taken together, there is a possibility that the drugs will interact with each other to cause unanticipated effect. Usually increase or decrease in the desired therapeutic effect. Drug-drug interaction can occur in the following sites 1. at the side of absorption, tetracycline is not absorbed from the GI tract if calcium product present in the stomach. 2. during biotransformation (CYP 450). 3. At the site of action, drug antagonism.

Drug-drug interaction 3. During excretion, digoxin and quinidine are both excreted from the same sites in the kidney. The quinidine will be excreted first because it is more competitive for these sites, resulting in increased serum levels of digoxin. 4. During distribution, aspirin competes with methotrexate for protein binding sites, and because aspirin is more competitive for the sites, resulting in increased release of methotrexate and so increase toxicity to tissues.

Adverse effect Adverse effect are undesired effect that may be unpleasant or even dangerous they can occur for many reasons: 1. The drug may have other effects on the body besides the therapeutic effect. 2. The patient is sensitive to the drug. 3. The patient is taking too much or too little of the drug. the nurse, as the most frequently administers medications, must be constantly alert for sign of drug reactions of various types.

Remember!!! With every drug use, unwanted effects must be taken into account. Before prescribing a drug, the physician should therefore assess the risk: benefit ratio. In this, knowledge of principal and adverse effects is a prerequisite.

Adverse Drug Reaction Adverse drug reactions are classified as predictable or unpredictable. A predictable drug reaction is related to the pharmacological actions of the drug. An unpredictable reaction is related to immunological response ( hypersensitivity reactions ) or non-immunological response 24

Drug Allergy It is defined as an adverse reaction to a drug by a specific immune response either directly to the drug or one or more of its metabolites alone, or to a drug bound to a body protein such as albumin, (Hapten). Such binding alters the structure of the drug/protein complex, rendering it antigenic.

Compliance Time course of drug concentration with irregular intake Time course of drug concentration with irregular intake

Adults >65 years old growing population 20% of hospitalizations for those >65 are due to medications they re taking

Pharmacokinetics Decrease in total body water (due to decrease in muscle mass) and increase in total body fat affects volume of distribution Water soluble drugs: lithium, aminoglycosides, alcohol, digoxin Serum levels may go up due to decreased volume of distribution Fat soluble: diazepam, thiopental, trazadone Half life increased with increase in body fat

Oxidative metabolism through cytochrome P450 system does decrease with aging, resulting in a decreased clearance of drugs

Pharmacokinetics: Excretion and Elimination GFR generally declines with aging, but is extremely variable 30% have little change 30% have moderate decrease 30% have severe decrease Serum creatinine is an unreliable marker If accuracy needed, do Cr Cl

Example: Creatinine Clearance vs. Age

Pharmacodynamics (PD) Definition: the time course and intensity of pharmacologic effect of a drug Age-related changes: sensitivity to sedation and psychomotor impairment with benzodiazepines level and duration of pain relief with narcotic agents drowsiness and lateral sway with alcohol HR response to beta-blockers sensitivity to anti-cholinergic agents cardiac sensitivity to digoxin

Factors contributing to adverse drug reactions in elderly patients Heart, kidney, liver, thyroid Orthostatic hypotension, when they standup, blood goes to their feet - weak sympathetic nervous system response to constrict veins and increase heart rate. Low thyroid function causes lower body temperature, metabolic rate, & heart rate. Polypharmacy How many prescription medications are too many? >4 or >6 Many elderly people receive 12 medications per day

Pediatric Dosing Traditionally, for less frequently used drugs, extrapolation is done from adult dose on a weight or surface area basis Problems Absorption may be more or less than adult Clearance of some drugs in children is affected by maturation, as well as size Cytochrome P450 enzyme system matures over time Glomerular filtration changes over time Drug targets may vary with age

CYP Enzymes CYP isoforms vary with age For example, clearance of midazolam by CYP 3A4 and 3A5 goes from 1.2 ml/min/kg to 9 ml/min/kg over first few months of life Carbamezapine (3A4) clearance faster in children than adults requires higher doses

Children are not Small Adults

Questions????? 27